Subtype
Diffuse Glioma
CI-CAN-00002519Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002519Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06038604 | Glioblastoma Psychosocial Support Program | completed | N/A | 11 | Duke UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT02441322 | Evaluating Therapeutic Response to Novo-TTF | completed | N/A | 30 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT04604158 |
| Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients |
| completed |
| N/A |
| 38 |
| Gillian GreshamOTHER |
| 1 |
| May 21, 2024 |
| clinicaltrials |
| NCT03712293 | ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy | completed | N/A | 9 | InSightecINDUSTRY | 1 | Mar 5, 2024 | clinicaltrials |
| NCT05604365 | FearLess in Cognitively Intact Patients With Glioma(FearLess) | completed | N/A | 22 | Virginia Commonwealth UniversityOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT03616860 | Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma | completed | N/A | 14 | InSightecINDUSTRY | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03458312 | Nurse-led Family and Network Consultations(CARES) | completed | N/A | 114 | Rigshospitalet, DenmarkOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT03557372 | Mathematical Model-Adapted Radiation In Glioblastoma | completed | N/A | 14 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT03841435 | Hypofractionated Radiotherapy for Recurrent DIPG | completed | N/A | 5 | University of CincinnatiOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT03538587 | Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers | completed | N/A | 10 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05896449 | Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin | completed | N/A | 49 | Medical University of WarsawOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT03915912 | Mindfulness Meditation in Glioma Patients | completed | N/A | 17 | Duke UniversityOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT04630379 | Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers | completed | N/A | 16 | Mayo ClinicOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT02296580 | A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 2 | Feb 2, 2023 | clinicaltrials |
| NCT03276286 | Nativis Voyager for Newly Diagnosed GBM(NAT109) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 1 | Feb 2, 2023 | clinicaltrials |
| NCT02274987 | Molecular Profiling for Individualized Treatment Plan for DIPG | completed | N/A | 38 | University of California, San FranciscoOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT02567539 | Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma | completed | N/A | 88 | Istituto Clinico HumanitasOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT04596930 | MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma(EMITT) | completed | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT00103038 | Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | completed | N/A | 155 | OHSU Knight Cancer InstituteOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT02854644 | Study of the Anti-tumoral Immune Response(ERISA) | completed | N/A | 167 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03775369 | Glioma and Exercising | completed | N/A | 39 | University Hospital, Basel, SwitzerlandOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT03390569 | Exercise in Patients With Glioblastoma | completed | N/A | 54 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05028400 | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery(LSCI-NSURG) | completed | N/A | 20 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02359097 | Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma | completed | N/A | 29 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT04516733 | Precoce Medical Care by the Mobil Support for Patients With Glioblastoma(GLIOSUPPORT) | completed | N/A | 35 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT02013297 | Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)(SBRT) | completed | N/A | 61 | Centre Leon BerardOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT02379572 | Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas | completed | N/A | 315 | University Hospital TuebingenOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT02919865 | MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas | completed | N/A | 50 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT03212157 | GlucoCEST MRI in Oncology | completed | N/A | 15 | University College, LondonOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT01878266 | Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children | completed | N/A | 119 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT02076152 | FMISO PET Study of Glioblastoma | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT01754350 | Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma(ERGO2) | completed | N/A | 50 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04790097 | FET-PET Directed Simultaneous In-field Boost for Primary GBM(dualFETboost) | completed | N/A | 17 | Prof. Franciszek Lukaszczyk Memorial Oncology CenterOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT00400322 | Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection | completed | N/A | 42 | Karolinska InstitutetOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT00979810 | Image-Guided Stereotactic Biopsy of High Grade Gliomas | completed | N/A | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03471546 | Early Palliative Care Intervention in Malignant Glioma | completed | N/A | 12 | Duke UniversityOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT03323450 | Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory | completed | N/A | 20 | Virginia Commonwealth UniversityOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT02082119 | Hypofractionated IMRT With Temozolomide for HGG | completed | N/A | 82 | Istituto Clinico HumanitasOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT01987830 | Bevacizumab w / Temozolomide PET & Vascular MRI For GBM | completed | N/A | 13 | Massachusetts General HospitalOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT02903784 | Neural Basis of Language Processing(BNL) | completed | N/A | 63 | University Hospital, MontpellierOTHER | 0 | Sep 2, 2020 | clinicaltrials |
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | completed | N/A | 37 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT02431572 | A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT01165671 | Carbon Ion Radiotherapy for Primary Glioblastoma(CLEOPATRA) | completed | N/A | 100 | University Hospital HeidelbergOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT02520492 | Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma(GMaPIC) | completed | N/A | 40 | Centre Jean PerrinOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT01540513 | PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404 | completed | N/A | 12 | University of Wisconsin, MadisonOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT02374255 | Improving Goals of Care Discussion in Advanced Cancer Patients | completed | N/A | 265 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT03626896 | Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients | completed | N/A | 6 | NaviFUS CorporationINDUSTRY | 1 | Jun 21, 2019 | clinicaltrials |
| NCT01478854 | Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide | completed | N/A | 33 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03075514 | Ketogenic Diets as an Adjuvant Therapy in Glioblastoma(KEATING) | completed | N/A | 12 | University of LiverpoolOTHER | 1 | Apr 4, 2019 | clinicaltrials |
| NCT02410577 | 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jul 31, 2024source: clinicaltrials